EichorEICHOR
Location: Cambridge Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Cambridge

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Phase 2 · Research Site · Alexion Pharmaceuticals, Inc. · NCT07157787A Trial of "APL-9796'' in Adults With Pulmonary Hypertension
Phase 2 · Royal Papworth Hospital · Apollo Therapeutics Ltd · NCT06846554A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Merck Sharp & Dohme LLC · NCT06136559Treatment of Post Traumatic Knee Osteoarthritis With Extracorporeal Shockwave Therapy
NA · Spaulding Cambridge Hospital · Spaulding Rehabilitation Hospital · NCT06686680Methods of T Cell Depletion Trial (MoTD)
Phase 2 · Addenbrookes Hospital · University of Birmingham · NCT04888741A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Gr
Phase 2 · Addenbrookes Hospital /ID# 272162 · AbbVie · NCT06682988A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Phase 1 · Pfizer · NCT07206225Metabolic Phenotyping in vEDS
Phase N/A · Translational Research Facility, Cambridge Clinical Research · Cambridge University Hospitals NHS Foundation Trust · NCT07516496STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06960213A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Com
Phase 1/Phase 2 · Research Site · AstraZeneca · NCT06188520Optical Neuroimaging and Cognition
Phase N/A · Univeristy of Cambridge · University of Cambridge · NCT05460143A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Phase 1 · Cambridge University Hospitals NHS Foundation Trust · Fate Therapeutics · NCT06308978The Oxford Risk Factors And Non-Invasive Imaging Study
Phase N/A · Royal Papworth Hospital NHS Trust · University of Oxford · NCT05169333A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Phase 1 · Pfizer · NCT07090499Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Cambridge Cardiac Care Centre · Amgen · NCT07037433A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Sele
NA · Cambridge University Hospitals NHS Trust · Alimentiv Inc. · NCT07363044A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy
Phase 2 · Cambridge University Hospitals NHS Trust · University of Leicester · NCT04663204Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Phase N/A · Cambridge Medical Center · PrECOG, LLC. · NCT06538038Mechanisms of Open and Hidden Placebo in Stroke Recovery
NA · Spaulding Hospital Cambridge · Spaulding Rehabilitation Hospital · NCT05832567Registry for Patients With Lipodystrophy
Phase N/A · University of Cambridge Metabolic Research Laboratories · University of Ulm · NCT03553420Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
Phase 2 · Addenbrooke's Hospital · Cambridge University Hospitals NHS Foundation Trust · NCT05093231A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers
NA · Addenbrooke's Hospital · University College, London · NCT05604963A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Addenbrooke's Hospital · Eli Lilly and Company · NCT07222332A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Phase 2 · Investigational Site Number: 8260004 · Sanofi · NCT06958536Home Versus Hospital Based NIV Care in MND
NA · Royal Paworth Hospital · Papworth Hospital NHS Foundation Trust · NCT06844370A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorecta
Phase 1 · Addenbrookes Hospital · Hoffmann-La Roche · NCT04929223A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Addenbrooke's Hospital · Celgene · NCT05519085A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · Bristol-Myers Squibb · NCT06976216BEARS Training Package to Maximise Hearing Abilities in Older Children and Teenagers With Bilateral Cochlear Implants
NA · Emmeline Centre for Hearing Implants · Guy's and St Thomas' NHS Foundation Trust · NCT05808543
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.